Open AccessRe-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
Author(s) -
L. Valor,
Carla Dorn,
Bernhard Manger,
Georg Schett,
Arnd Kleyer
Publication year - 2022
Publication title -
rheumatology advances in practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.539
H-Index - 4
ISSN - 2514-1775
DOI - 10.1093/rap/rkac079
Subject(s) - psoriatic arthritis , tnf inhibitor , medicine , tumor necrosis factor alpha , arthritis , psoriasis , pharmacology , immunology , etanercept
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom